Institut National de la Santé et de la Recherche Médicale, U 855, Lyon 69372, France ; Université de Lyon, Lyon 69008, France ; Université Lyon 1, Villeurbanne 69622, France ; AgroParisTech, ENGREF, Paris F-75732, France.
Mol Metab. 2012 Dec 7;2(1):47-53. doi: 10.1016/j.molmet.2012.11.003. eCollection 2012.
Portal vein glucose sensors detect variations in glycemia to induce a nervous signal that influences food intake and glucose homeostasis. Previous experiments using high infusions of glucose suggested a metabolic sensing involving glucose transporter 2 (GLUT2). Here we evaluated the afferent route for the signal and candidate molecules for detecting low glucose fluxes. Common hepatic branch vagotomy did not abolish the anorectic effect of portal glucose, indicating dorsal transmission. GLUT2-null mice reduced their food intake in response to portal glucose signal initiated by protein-enriched diet. A similar response of Trpm5-null mice and portal infusions of sweeteners also excluded sugar taste receptors. Conversely, infusions of alpha-methylglucose, but not 3-O-methylglucose, decreased food intake, while phlorizin prevented the effect of glucose. This suggested sensing through SGLT3, which was expressed in the portal area. From these results we propose a finely tuned dual mechanism for portal glucose sensing that responds to different physiological conditions.
门静脉葡萄糖传感器检测血糖变化,以诱导影响食物摄入和葡萄糖稳态的神经信号。先前使用高浓度葡萄糖输注的实验表明存在涉及葡萄糖转运蛋白 2 (GLUT2) 的代谢感应。在这里,我们评估了信号的传入途径和检测低葡萄糖通量的候选分子。肝总分支迷走神经切断术并未消除门静脉葡萄糖的厌食作用,表明存在背侧传递。GLUT2 基因敲除小鼠对富含蛋白质的饮食引发的门静脉葡萄糖信号作出减少食物摄入的反应。Trpm5 基因敲除小鼠和门静脉甜味剂输注也排除了糖味觉受体的作用。相反,α-甲基葡萄糖输注而不是 3-O-甲基葡萄糖输注会减少食物摄入,而根皮苷则阻止了葡萄糖的作用。这表明通过 SGLT3 进行感应,SGLT3 在门静脉区域表达。根据这些结果,我们提出了门静脉葡萄糖感应的精细双重机制,该机制对不同的生理条件作出反应。